| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.00072 | 1 |